Clinical Trials on Amino Acid Metabolism, Inborn Errors
Total 4778 results
-
National Taiwan University HospitalPTC TherapeuticsCompletedAromatic L-amino Acid Decarboxylase (AADC) DeficiencyTaiwan
-
Medical University of GdanskCompletedSepsis | Amino Acid Catabolism DisorderPoland
-
Institut National de Recherche pour l'Agriculture...University of Helsinki; AgroParisTechCompleted
-
Hvidovre University HospitalOdense University HospitalActive, not recruitingHypophosphatasia (HPP)Denmark
-
University of FloridaCompleted
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
National Institute of Mental Health (NIMH)CompletedHealthy | PET Scan | Glutamate Receptor | mGlur5 Protein | Excitatory Amino Acid Receptors | Drug KineticsUnited States
-
University of FloridaDiabetes SentryTerminatedClinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease PopulationGlycogen Storage DiseaseUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Saudi Arabian Cultural Bureau...Unknown
-
AlexionWithdrawn
-
CENTOGENE GmbH RostockWithdrawnDefective MineralizationGermany, Sri Lanka, India
-
Alexion PharmaceuticalsCompletedHypophosphatasiaUnited States, Canada
-
Alexion PharmaceuticalsCompletedHypophosphatasiaUnited States, United Arab Emirates, United Kingdom
-
Alexion PharmaceuticalsCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
National Human Genome Research Institute (NHGRI)TerminatedPulmonary Fibrosis | Metabolic Disease | Oculocutaneous Albinism | Hermansky-Pudlak Syndrome (HPS) | Platelet Storage Pool DeficiencyUnited States
-
Massachusetts General HospitalCompletedDietary Intake of Branched Chain Amino AcidsUnited States
-
Istanbul UniversityBiruni UniversityNot yet recruitingLipid Storage DiseaseTurkey
-
National Institutes of Health Clinical Center (CC)Active, not recruiting
-
Nantes University HospitalActive, not recruitingHYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism (HYPOCHOL)HypobetalipoproteinemiaFrance
-
Rennes University HospitalCompleted
-
University of Campinas, BrazilCompletedHypoalphalipoproteinemiaBrazil
-
Sanquin Research & Blood Bank DivisionsRadboud University Medical Center; Maastricht University Medical Center; Atrium...Completed
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)United States, Netherlands, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
Spark TherapeuticsActive, not recruitingLysosomal Storage Diseases | Glycogen Storage Disease Type II | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Canada, Netherlands, France, Denmark, Germany, Italy, United Kingdom
-
Spark TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Italy, United Kingdom, Netherlands, France, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States, Israel, France, United Kingdom
-
Ultragenyx Pharmaceutical IncCompletedGSD1Netherlands, United States, Canada, Spain
-
Mendel TuchmanEunice Kennedy Shriver National Institute of Child Health and Human Development...UnknownInborn Errors of MetabolismUnited States
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Canada
-
University of Wisconsin, MadisonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsEnrolling by invitationIron Overload | Hemosiderosis | HemochromatosisUnited States
-
University of Wisconsin, MadisonCompleted
-
Hospices Civils de LyonCompleted
-
Seoul National University HospitalCompleted
-
Instituto Nacional de Ciencias Medicas y Nutricion...Instituto Nacional de Cardiologia Ignacio ChavezCompleted
-
Maastricht University Medical CenterAnnadal stichtingUnknownHemochromatosisNetherlands, Belgium
-
University of BergenHaukeland University Hospital; Helse Fonna; University Hospital, AkershusUnknown
-
Kasper DideriksenUnknownMuscle Protein Synthesis | Meat Protein Supplements | Protein Absorption and Amino Acid AvailabilityDenmark
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedSmith-Lemli-Opitz SyndromeUnited States
-
TRPHARMKlinar CRO; Damagen Genetic Diagnostic CenterEnrolling by invitationXanthomatosis, CerebrotendinousTurkey
-
University of TorontoUnknownCardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
Kuhnil Pharmaceutical Co., Ltd.UnknownHyperlipidemia, Familial CombinedKorea, Republic of
-
Alexion Pharmaceuticals, Inc.Xcenda, LLCActive, not recruitingHypophosphatasiaUnited States
-
Alexion PharmaceuticalsWithdrawn
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Taiwan, United Kingdom, Australia, Canada, Germany, Spain